Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare,…
An international group of researchers has set up a brain-machine interface between cultured nerve cells…
Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes…
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI…
A Swiss research group has developed tiny plastic particles that could carry gene therapies to…
The Swiss biotech ImmunOs Therapeutics has raised a Series A round of €13.7M (CHF 15M)…
An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding…
Scientists have developed a method for storing DNA data in 3D-printed objects, which could one…
A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor…
Versantis has raised a Series B of €14.6M (CHF 16M) to advance its treatment for…
A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict…